| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $365K | +0.0% |
| R&D Expense | $8.8M | -17.0% |
| SG&A Expense | $4.4M | +8.9% |
| Operating Income | -$15.3M | +11.3% |
| Pre-tax Income | -$16.3M | -18.8% |
| Income Tax | $0 | — |
| Net Income | -$16.3M | -18.8% |
| EPS (Basic) | -$0.51 | +16.4% |
| EPS (Diluted) | -$0.51 | +16.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.7M | +15.2% |
| Accounts Receivable | $365K | +0.0% |
| Current Assets | $16.3M | +11.4% |
| Total Assets | $17.8M | +7.2% |
| Current Liabilities | $1.5M | -45.3% |
| Total Liabilities | $3.3M | +2.7% |
| Stockholders' Equity | $14.5M | +8.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | -3.1% |
| Investing Cash Flow | -$84K | -29.4% |
| Financing Cash Flow | $16.1M | -3.6% |